Diagnosis of tuberculosis and other diseases using exhaled breath
Disclosed are methods and devices for analyzing aerosol particles in exhaled breath using diagnostic tools that enable rapid, low cost and autonomous point of care assays for several diseases including respiratory tract diseases. Disclosed are methods and devices for capturing exhaled breath aerosols in a packed bed column and analyzing exhaled captured breath aerosols for tuberculosis diagnosis.
1 . A system for diagnosing respiratory diseases in an individual using exhaled breath, the system including:
a sample extraction component configured to receive an individual's face for extracting breath aerosol (EBA) particles in exhaled breath expelled into a flow of air fed into the sample extraction component;
a sample capture component fluidly connected to the sample extraction component and configured to collect the EBA particles as a condensed liquid sample; and
a packed bed column disposed downstream of the sample capture component and configured to selectively capture the EBA particles from the condensed liquid sample onto the packed bed.
2 . The system of claim 1 , further including:
means to elute the EBA particles from the packed bed using one or more solvents; and
a diagnostic device for analyzing the EBA particles in the one or more solvents.
3 . The system of claim 2 , wherein the diagnostic device includes one or more of PCR, rt-PCR, immuno-based assay, mass spectrometer (MS), MALDI-MS, ESI-MS, GC-MS, GC-IMS, or MALDI-TOFMS.
4 . The system of claim 2 , wherein the means to elute the EBA particles from the packed bed using one or more solvents includes at least one of one or more syringes, and one or more pumps to flush the packed bed with the one or more solvents.
5 . The system of claim 2 , wherein the one or more solvents includes at least one of acetonitrile, methanol, acid, isopropanol, the remaining being water.
6 . The system of claim 1 , wherein the EBA particles include one or more of microbes, virus, metabolite biomarkers, lipid biomarkers, or proteomic biomarkers characteristic of the respiratory disease.
7 . The system of claim 6 , wherein the lipid biomarkers includes biomarkers characteristic of Mtb.
8 . The system of claim 1 , further comprising an air pump, wherein the air pump provides the flow of air to carry the exhaled breath from the sample extraction component into an impactor.
9 . The system of claim 8 , wherein the impactor is configured to separate the EBA particles from exhaled breath to produce the condensed liquid sample.
10 . The system of claim 8 , wherein the impactor includes one or more of a cyclone, a wetted wall cyclone, one or more wetted film impactors, a virtual impactor, or an impinger.
11 . The system of claim 1 , wherein the sample extraction component includes one or more of a cone shaped device, a shroud, CPR rescue mask, a CPAP mask, a ventilator mask, or a medical universal mouthpiece.
12 . The system of claim 1 , further including one or more chilling devices configured to be in thermal communication with the sample capture component.
13 . The system of claim 1 , further including one or more sensors configured be in fluid communication with the sample extraction component, wherein the output of the one or more sensors is used to determine a total cumulative volume of exhaled breath aerosol particles entering the sample capture component.
14 . The system of claim 13 , wherein the one or more sensors includes one or more of a CO 2 sensor, an oxygen sensor, a humidity sensor, an optical particle size counter, an aerodynamic particle sizer, or a nephelometer.
15 . The system of claim 1 , wherein the condensed liquid sample is transferred to the packed bed column using one or more of a dispensing pump or a robotic sample transfer system.
16 . The system of claim 1 , wherein the packed bed column includes solid particles of one or more of resins, cellulose, silica, agarose, or hydrated Fe 3 O 4 nanoparticles.
17 . The system of claim 1 , wherein the packed bed column includes resin beads having C18 functional groups on the surface.
18 . A method for diagnosing respiratory diseases in an individual using exhaled breath, the method comprising:
extracting EBA particles expelled into a flow of air fed into a sample extraction component configured to receive an individual's face;
collecting the EBA particles from exhaled breath and air as a condensed liquid sample using a sample capture component; and
capturing the EBA particles in the condensed liquid sample using a packed bed column disposed downstream of the sample capture component to selectively capture the EBA particles from the condensed liquid sample onto the packed bed.
19 . The method of claim 18 , further including:
eluting the EBA particles from the packed bed using one or more solvents; and
analyzing the EBA particles comprised in the one or more solvents.
20 . The method of claim 19 , wherein analyzing further comprises detecting one or more of lipid biomarkers PS 24:4, PI 18:4, Cer 8:0, DG O-8:0, and PI 20:4 to determine the presence or absence of a respiratory disease.
21 . A system for diagnosis of a respiratory disease using exhaled breath, the system comprising:
a sample extraction component configured to receive an individual's face for extracting non-volatile exhaled breath aerosol (EBA) particles in exhaled breath expelled into a flow of air fed into the sample extraction component;
an air pump configured to provide the flow of sheath air fed into the sample extraction component to transport the non-volatile EBA particles through the sample extraction component;
a sample capture component fluidly connected to the sample extraction component and configured to collect the non-volatile EBA particles as a condensed liquid sample; and
a sample analysis subsystem fluidly connected to the sample capture component.
22 . The system of claim 21 , wherein the sample analysis system further includes:
a sample processing component configured to produce a sample spot of the condensed liquid sample including the non-volatile EBA particles on a sample plate; and
a diagnostic device for analyzing the non-volatile EBA particles in the treated sample spot on the sample plate.
23 . The system of claim 21 , further including one or more chilling devices configured to be in thermal communication with the sample capture component.